Cargando…
The roles of tumor-derived exosomes in non-small cell lung cancer and their clinical implications
Non-small cell lung cancer (NSCLC) accounts for approximately 85% of lung cancer cases, and it is one of the leading causes of cancer death in both men and women worldwide due to diagnosis in the advanced stage, rapid metastasis, and recurrence. At present, precision molecular targeted therapeutics...
Autores principales: | Zheng, Hongmei, Zhan, Yuting, Liu, Sile, Lu, Junmi, Luo, Jiadi, Feng, Juan, Fan, Songqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137883/ https://www.ncbi.nlm.nih.gov/pubmed/30217217 http://dx.doi.org/10.1186/s13046-018-0901-5 |
Ejemplares similares
-
MicroRNAs associated with therapy of non-small cell lung cancer
por: Lu, Junmi, et al.
Publicado: (2018) -
Expression of DR5 and c-FLIP proteins as novel prognostic biomarkers for non-small cell lung cancer patients treated with surgical resection and chemotherapy
por: Zheng, Hongmei, et al.
Publicado: (2019) -
Elevated expression of mcl-1 inhibits apoptosis and predicts poor prognosis in patients with surgically resected non-small cell lung cancer
por: Wen, Qiuyuan, et al.
Publicado: (2019) -
Prognostic analysis of patients with mutant and wild-type EGFR gene lung adenocarcinoma
por: Zheng, Hongmei, et al.
Publicado: (2019) -
Overexpression of p-Akt, p-mTOR and p-eIF4E proteins associates with metastasis and unfavorable prognosis in non-small cell lung cancer
por: Lu, Junmi, et al.
Publicado: (2020)